Bond.az White LogoBond.az Black Logo

Benchmark maintains Texas Roadhouse Hold rating

Benchmark maintains Texas Roadhouse Hold rating. Stock at $177.06, analyst targets $165-$234.

Harper Clark
ByHarper Clark- Senior Editor
|
0

Benchmark reiterated a Hold rating on Texas Roadhouse after a client meeting with senior management.

The stock trades at $177.06 with a market cap of $11.64 billion. Bond.az data suggests shares are slightly overvalued.

Analyst Todd Brooks met executives including CEO Jerry Morgan and CFO Mike Lenihan. Brooks noted the strength of the business model.

Analyst price targets range from $165 to $234. Benchmark said it would consider a more constructive stance after a pullback.

In recent news, Texas Roadhouse reported Q1 EPS of $1.87, beating estimates, while revenue of $1.63B slightly missed.

More News
Today / 13:44
|
314

Piper Sandler reiterates Boston Properties stock rating

Piper Sandler reaffirms Overweight rating on Boston Properties stock with $75 target. AI demand driving office market changes.

0
Today / 13:04
|
455

Benchmark Reiterates Hold on Dine Brands Stock

Benchmark reiterates Hold on Dine Brands Global shares after $100 million buyback plan. Stock up 9.3% last week.

0
Today / 13:02
|
431

GEN Restaurant Group Hold maintained

Benchmark maintains Hold on GEN Restaurant Group after Q1 2026 results miss estimates on revenue and profit.

0
Today / 12:25
|
786

Orrstown Gets Neutral Rating from DA Davidson

DA Davidson gives Orrstown Financial a neutral rating with $41 target. Strong deposit base and 11-year dividend growth highlight the bank's stability.

0
Today / 12:23
|
658

DA Davidson Initiates Unity Bancorp with Buy Rating

DA Davidson initiates Unity Bancorp with buy rating and $68 target. Strong growth outlook and dividend history highlighted.

0
Today / 12:04
|
583

Bitdeer Price Target Raised to $19 by Needham

Needham raised Bitdeer price target to $19, maintaining Buy. Tydal discussions advanced; stock up 40% in 6 months.

0
Today / 12:03
|
373

Solventum stock Outperform rating by Wedbush

Wedbush initiates Solventum coverage at Outperform with $94 target. Activist Trian pushes for portfolio simplification. Stock trades at $74.42.

0
Today / 12:02
|
275

Needham Cuts Cellebrite Target to $15 on Valuation

Needham lowered Cellebrite price target to $15 from $18, maintaining Buy. Strong Q1 results, growth products doubling, and FedRAMP authorization highlight the company's performance.

0
Today / 11:43
|
444

Prestige Brands Price Target Cut to $72 by Canaccord

Canaccord cuts Prestige Brands price target to $72 after sales miss. Despite challenges, the company eyes growth through acquisitions.

0
Today / 11:32
|
467

Canaccord Reaffirms GH Research Stock Rating on Phase 3 Progress

Canaccord Genuity keeps Buy rating on GH Research stock as Phase 3 program for GH001 advances. Key financial highlights included.

0
Today / 11:30
|
644

Biogen Stock: Alzheimer Drug Shows Promise

Biogen's Alzheimer drug diranersen shows positive Phase 2 results. Stock analysis and future outlook from Bond.az.

0
Today / 11:23
|
996

Needham cuts Globant target to $50 on lower multiples

Needham cuts Globant price target to $50 on lower multiples. Bond.az provides detailed analysis and insights.

0
...
Benchmark maintains Texas Roadhouse Hold rating | Bond.az